ArticleACR open rheumatology2025

Pharmacokinetics and Safety of Oral Pyrophosphate in Systemic Sclerosis Patients-A Pilot Study.

Gergely Bodor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.